iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea
· Delayed Price · Currency is KRW 3,740.00
-45.00 (-1.19%)
Apr 29, 2026, 3:30 PM KST
iNtRON Biotechnology Revenue
In the year 2025, iNtRON Biotechnology had annual revenue of 5.74B KRW, down -10.56%. iNtRON Biotechnology had revenue of 1.70B in the quarter ending December 31, 2025, with 12.02% growth.
Revenue
5.74B
Revenue Growth
-10.56%
P/S Ratio
20.85
Revenue / Employee
78.63M
Employees
73
Market Cap
119.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.74B | -677.59M | -10.56% |
| Dec 31, 2024 | 6.42B | -3.17B | -33.05% |
| Dec 31, 2023 | 9.59B | -4.42B | -31.57% |
| Dec 31, 2022 | 14.01B | -15.30B | -52.21% |
| Dec 31, 2021 | 29.31B | -16.13B | -35.49% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amicogen | 41.98B |
| Oncocross | 370.46M |
| IMB Dx | 5.33B |
| CG Invites | 27.39B |
| GeneOne Life Science | 23.04B |
| ENCell | 5.26B |
| Vaxcell-Bio Therapeutics | 1.90B |
| MedPacto | 3.90B |